(Q33258307)

24 July 2017

1 reference

title

Recombinant protective antigen 102 (rPA102): profile of a second-generation anthrax vaccine (English)

1 reference

24 July 2017

1

Wendy A Keitel

1 reference

24 July 2017

publication date

1 August 2006

1 reference

Expert Review of Vaccines

24 July 2017

published in

1 reference

24 July 2017

volume

5

1 reference

24 July 2017

issue

4

1 reference

24 July 2017

page(s)

417-430

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

24 July 2017

1 reference

Recognition and management of anthrax--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Anthrax as a biological weapon, 2002: updated recommendations for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Identification of the cellular receptor for anthrax toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Crystal structure of the anthrax toxin protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

A phenylalanine clamp catalyzes protein translocation through the anthrax toxin pore

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

A model of anthrax toxin lethal factor bound to protective antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Anthrax lethal toxin induces human endothelial cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Anthrax lethal toxin paralyzes neutrophil actin-based motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Antiplatelet activities of anthrax lethal toxin are associated with suppressed p42/44 and p38 mitogen-activated protein kinase pathways in the platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Bacillus anthracis oedema toxin as a cause of tissue necrosis and cell type-specific cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Effect of the lower molecular capsule released from the cell surface of Bacillus anthracis on the pathogenesis of anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Molecular basis for improved anthrax vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Comparison of the immunological memory after DNA vaccination and protein vaccination against anthrax in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

In vitro correlate of immunity in a rabbit model of inhalational anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Immunological correlates for protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Genetic immunization against anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Induction of opsonic antibodies to the gamma-D-glutamic acid capsule of Bacillus anthracis by immunization with a synthetic peptide-carrier protein conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

The science of Louis Pasteur: a reconsideration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Human live anthrax vaccine in the former USSR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Anthrax and the wool trade. 1902.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

The Sverdlovsk anthrax outbreak of 1979

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Index case of fatal inhalational anthrax due to bioterrorism in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Scalable purification of Bacillus anthracis protective antigen from Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Bacillus spores for vaccine delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Induction of protective immunity against lethal anthrax challenge with a patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

A soluble receptor decoy protects rats against anthrax lethal toxin challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

A phase 1 study of PAmAb, a fully human monoclonal antibody against Bacillus anthracis protective antigen, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Cloning of the protective antigen gene of Bacillus anthracis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.417

21 January 2018

Identifiers

DOI

10.1586/14760584.5.4.417

1 reference

24 July 2017

1 reference